Sublocade treatment has been proven to be an effective remedy to treat opioid use disorder, including heroin addiction. Buprenorphine is slowly released throughout the individual’s bloodstream during Sublocade treatment, which is meant to cause a consistent stimulation within the opioid receptors. This is helpful to the patient primarily because this process naturally lessens the intensity of the developed side-effects that are likely being experienced by this time.
Among the most notable of these side-effects includes the wide variety of withdrawal symptoms that appear very soon after the use of opioid drugs is suddenly eliminated from the patient’s life.
After a thorough clinical study conducted by the DailyMed that took place over the 24 weeks, industry professionals have been able to evaluate the treatment options better to be considered for individuals struggling with opioid use disorder. The results concluded that nearly 30% of those who took Sublocade, along with the appropriate 1:1 counseling sessions, chose not to use any other opioid drugs for at least 80% of the remaining time of the study. This result was compared to the dismal 2% of the participants who were chosen to take the placebo, meaning they unknowingly did not receive any treatment.